Skip to main content

Animations

MJFF Publications

3071 - 3080 of 6310 Results
Title
Year
  • Year
  • 2019
  • 2021
  • 2013
  • 2022
  • 2021
  • 2018
  • 2020
  • 2021
  • 2016
  • 2022
  • Summary Details
    OPEN
    Title: Dopamine Receptor D3 Expression Is Altered in CD4+ T-Cells From Parkinson's Disease Patients and Its Pharmacologic Inhibition Attenuates the Motor Impairment in a Mouse Model
    Journal Name: Frontiers in Immunology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fimmu.2019.00981
    Citation Count: 51
  • Summary Details
    OPEN
    Title: Differential Effects of Pathological Beta Burst Dynamics Between Parkinson’s Disease Phenotypes Across Different Movements
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2021.733203
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Population‐specific frequencies for LRRK2 susceptibility variants in the genetic epidemiology of Parkinson's disease (GEO‐PD) consortium
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.25600
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Diagnostic classification of Parkinson’s disease based on non-motor manifestations and machine learning strategies
    Journal Name: Neural Computing and Applications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00521-022-07256-8
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Improved motor outcome prediction in Parkinson's disease applying deep learning to DaTscan SPECT images
    Journal Name: Computers in Biology and Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.compbiomed.2021.104312
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Active site alanine mutations convert deubiquitinases into high‐affinity ubiquitin‐binding proteins
    Journal Name: EMBO reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/embr.201745680
    Citation Count: 55
  • Summary Details
    OPEN
    Title: Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.10.019
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28779
    Citation Count: 135
  • Summary Details
    OPEN
    Title: Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-016-0072-9
    Citation Count: 239
  • Summary Details
    OPEN
    Title: Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration
    Journal Name: Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.cell.2021.12.041
    Citation Count: 235
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.